Correction to: J ImmunoTher Cancer
https://doi.org/10.1186/s40425-018-0445-4
Following publication of the original article [1], an error was noted in the GAPDH in the western blot depicted in Figure 4b. The GAPDH lanes for the experiment have been updated. The corrected Fig. 4 can be seen below.
The error does not affect the findings of the experiment.
Reference
Fenerty, et al. Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition. J ImmunoTher Cancer. 2018;6:133. https://doi.org/10.1186/s40425-018-0445-4.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Fenerty, K.E., Padget, M., Wolfson, B. et al. Correction to: Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition. j. immunotherapy cancer 7, 234 (2019). https://doi.org/10.1186/s40425-019-0715-9
Published:
DOI: https://doi.org/10.1186/s40425-019-0715-9